Abstract. Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 1 (SPOCK1) has been reported to promote the growth and progression of various tumors. In this study, we focus on assessing the effect of SPOCK1 on proliferation, migration and invasion in glioma cells and elucidating its related mechanisms. The results of our present study demonstrated that overexpression of SPOCK1 promoted the proliferation and inhibited apoptosis in glioma cells. Additionally, overexpression of SPOCK1 promoted the migration and invasion potential of glioma cells. Moreover, we demonstrated that PI3K/AKT and Wnt/β-catenin signaling pathways were activated by SPOCK1 over expression. SPOCK1 silencing has precisely the opposite effect. In conclusion, our study suggests that SPOCK1 promotes proliferation, migration and invasion in glioma cells by activating PI3K/AKT and Wnt/β-catenin pathways, which provides a potential theoretical basis for clinical treatment of glioma.
Introduction
Brain glioma, the most common primary brain tumor is thought to be one of the deadliest forms of cancer and over 2/3 of the patients were diagnosed with malignant glioma (1).
In the last twenty years, although the surgical techniques and treatment strategy have been greatly improved, the prognosis of patients with malignant glioma is still poor (2, 3) . The oneyear survival rate of glioma is <30% (4) . The main biological characteristics of glioma is invasive growth, which results in incomplete surgery, high rate of recurrence and short survival period (5, 6) . As the understanding of tumor mechanism has improved, the incidence and development of glioma is considered the result of interactions among various abnormally expressed genes. Thus, finding genes related to growth and invasiveness of glioma and revealing the possible mechanism has significant meaning in treatment of glioma.
SPOCK1, an oncogene, is frequently overexpressed in various cancer tissues (7) . Increasing evidence has demonstrated that SPOCK1 plays important roles in proliferation, migration and invasion of tumor cells. Study by Miao et al showed that SPOCK1 as a target gene of TGF-β1 could regulate lung cancer cell epithelial-mesenchymal transition and silencing of SPOCK1 obviously inhibited the proliferation and invasion of lung cancer cells (8) . Previous study also found that SPOCK1, upregulated by CHD1L, promoted proliferation and invasion of hepatoma carcinoma cells (9) . SPOCK1 was able to promote proliferation and metastasis of gallbladder cancer cells trough the PI3K/AKT signaling pathway (10) . The expression levels of SPOCK1 in malignant glioma and pilocytic astrocytoma exhibited significant differences (11) , which indicated that SPOCK1 had important effect on genesis and progression in glioma. However, the effect of SPOCK1 on proliferation and invasion of glioma cells and the underlying mechanisms are far from clear.
In this study, we investigated the effect of SPOCK1 on the proliferation, apoptosis, migration and invasion through overexpressing exogenous and RNA-interfered endogenous SPOCK1 expression in glioma cells.
Materials and methods
Cell lines and culture. The glioma cell line U251 and U87 MG cells were obtained from Type Culture Collection of Chinese SPOCK1 promotes the proliferation, migration and invasion of glioma cells through PI3K/AKT and Wnt/β-catenin signaling pathways
Academy of Sciences and American Type Culture Collection, respectively. The U251 cells were maintained in DMEM (Gibco, Carlsbad, CA, USA). The U87 MG cells were cultured in MEM (Gibco). All the cells were supplemented with 10% fetal bovine serum (Hyclone, Logan, UT, USA), 100 µg/ml streptomycin and 100 U/ml penicillin (Hyclone), cultured at 37˚C, in a humidified environment of 5% CO 2 atmosphere.
Construction of plasmids and generation of stable cell lines.
The sequences of SPOCK1 shRNA and negative control (NC) shRNA were 5'-GUAAUGAGGAGGGCUAUUA-3' and 5'-TTCTCCGAACGTGTCACGT-3', respectively. The sh-SPOCK1 and sh-NC were cloned into pGCsi-H1 vector (Genechem, Shanghai, China) separately and transfected into U87 MG cells. The human full-length cDNA of SPOCK1 was inserted into pEGFP-N1 vector (Clontech, San Jose, CA, USA) and transfected into U251 cells. Control cells were transfected with pEGFP-N1 vector. After transfection for 24 h, 400 µg/ml G418 was added into U87 MG and U251 cells for 2 weeks to select stable SPOCK1-silencing/overexpressing clones. The mRNA and protein expression levels of SPOCK1 were determined by qPCR and western blotting. . Rabbit anti-p-PI3K (1:500) were obtained from Bioss (Beijing, China). Briefly, the cells were lysed in RIPA and then denatured. The protein concentration was measured using the BCA protein estimation kit (Beyotime, Shanghai, China). Protein samples were separated on an SDS-polyacrylamide gel and transferred to PvDF membranes. The membranes were blocked with 5% non-fat dry milk in PBS for 2 h at room temperature, and incubated with primary antibodies, respectively, at 4˚C overnight. After incubation with a secondary antibody the blots were visualized by ECL detection reagent (Beyotime).
Quantitative real-time polymerase chain reaction (qPCR).
Quantitative PCR was used to quantify the expression of mRNA in cultured cells. Briefly, total RNA was extracted with TRIzol reagent (Invitrogen, Carlsbad, CA, USA). The total RNA (1 µg) was reverse transcribed by a reverse transcriptase (Takara, Shiga, Japan). RNA expression was measured by qRT-PCR using the SYBR-Green method (Takara) according to the manufacturer's instructions. The primer sequences of SPOCK1 were as follows: SPOCK1 (forward, 5'-CACTG GGTTGGACCTTCGA-3'; reverse, 5'-CTTTGGTGGCTC AGGCTCT-3') and β-actin (forward, 5'-CTTAGTTGCGTT ACACCCTTTCTTG-3'; reverse, 5'-CTGTCACCTTCAC CGTTCCAGTT T-3'). β-actin was used as an internal reference gene to normalize the expression of detection genes. Relative quantification of gene was analyzed by the comparative threshold cycle (Ct) method. Flow cytometry for cell cycle analysis. For the cell cycle assay, the cells in exponential growth period were collected, washed twice with cold PBS, fixed in cold 70% ethanol at -20˚C. After washing with cold PBS the cells were incubated with 10 mg/ml Rnase A (Beyotime) and 1 mg/ml propidium iodide (Beyotime) at 37˚C for 30 min. Cell cycle was performed by flow cytometry (BD Biosciences, San Jose, CA, USA).
Colony formation assay. Cells were seeded into a six-well plate (200 cells per well). Cells were cultured at 37˚C with 5% CO 2 for 14 days until the clones were visible to the naked eye. Thereafter, the medium was removed and the cells were fixed with 4% paraformaldehyde, dyed with crystal violet. Under a microscope (Olympus, Tokyo, Japan) stained clones with cell number >50 were counted and digital images were taken.
Immunofluorescence (IF).
Cells grown on cover slips were fixed with 4% paraformaldehyde for 15 min at room temperature. Then the cells were permeabilized with 0.1% Triton-X-100 solution for 30 min. After washing with PBS, cells were blocked with 10% goat serum for 15 min at room temperature. Then, cells were incubated with mouse monoclonal anti-PCNA (1:50) in PBS with 10% goat serum at 4˚C overnight. After washing with PBS three times, cells were incubated with Cy3-conjugated anti-mouse secondary antibodies for 1 h at room temperature. The nuclei were counterstained with DAPI (Biosharp, Seattle, WA, USA). Under a magnification of x400, fluorescence images of 5 different microscopic fields were captured by a fluorescence microscope.
Wound healing assay. Cells were seeded in 12-well plates and incubated until >80% confluence. A straight wound was created by scratching with a 200-µl pipette tip. Floating cells were removed by washing with serum-free medium twice. The cells were then cultured in serum-free medium and allowed to migrate into the wound area. Images of the migrated cells were acquired with an inverted microscope (Olympus) at 0, 12, 24 h.
Transwell invasion assay.
Transwell chambers (Corning Inc., Corning, NY,. USA) were pre-coated with matrigel (BD Biosciences) at 37˚C for 2 h. Cells (10 4 ) in 200 µl serumfree medium were added to the upper compartment, and to the lower chamber was added 800 µl DMEM containing 20% FBS. Then the cells were incubated for 24 h at 37˚C with 5% CO 2 . A cotton swab was used to remove the non-invaded cells in the upper compartment. The invaded cells were fixed in 4% paraformaldehyde and stained with 0.1% crystal violet for 30 min. Under the microscope the cells were counted in five random sights.
Gelatin zymography assay. The samples were separated in 10% SDS polyacrylamide gel containing 0.2% gelatin in ice bath for 2.5 h. Then the gels were washed in eluent buffer (2.5% Triton X-100, 50 mM Tris-HCl, 5 mM CaCl 2 , 1 µM ZnCl 2 , pH 7.6) for 40 min, twice; equilibrated in developing buffer (50 mM Tris-HCl, 5 mM CaCl 2 , 1 µM ZnCl 2 , pH 7.6) for 20 min, twice; and finally put in incubation buffer (50 mM Tris-HCl, 5 mM CaCl 2 , 1 µM ZnCl 2 , 0.02% Brij, 0.2 M NaCl) at 37˚C for 40 h. Then, the gels were incubated with staining buffer (0.05% Coomassie blue G-250 in 45% methanol, 10% acetic acid, 30% methanoic acid) for 3 h and then washed with destaining buffer (45% methanol, 10% acetic acid) until clear bands appeared. The images were obtained by gel imaging system (Bio-Rad, Hercules, CA, USA) and the activities of MMPs were measured by densitometric analysis. Hoechst 33342 staining. Hoechst 33342 staining was performed to measure apoptotic morphology. Briefly, 5x10 4 cells were seeded on cover slips and fixed with 4% paraformaldehyde for 20 min at room temperature. After washing twice with PBS, the cells were stained with Hoechst 33342 for 5 min. Fluorescent images were acquired by a fluorescence microscopy (Olympus).
Statistical analysis.
All results are expressed as mean ± standard deviation (SD). Statistical analyses were performed using Student's t-test. A p-value of <0.05 was set as the significance level.
Results

Expression of the SPOCK1 gene in glioma cells.
To investigate the role of SPOCK1 in glioma cells, we chose U87 MG cells with higher SPOCK1 expression level for stable transfection with shRNA vector toward SPOCK1 and U251 cells, in which SPOCK1 is infrequently expressed, for stable transfection with SPOCK1 expression vector. The expression levels of SPOCK1 was measured by real-time PCR and western blot analysis. As shown in Fig. 1A and C, an efficient silencing of SPOCK1 protein and mRNA expression was shown in U87 MG cells transfected with the SPOCK1 shRNA compared with negative control group. An obvious high level of SPOCK1 protein and mRNA expression was apparent in U251 cells transfected with SPOCK1 expression vector (Fig. 1B and D) .
Effect of SPOCK1 on glioma cell proliferation. The effect of SPOCK1 on the proliferation of glioma cells were measured by CCK8 assay. As shown in Fig. 2A , silencing of SPOCK1 significantly inhibited the proliferation of U87 MG cells. While overexpression of SPOCK1 could promote the proliferation of U251 cells. Additionally, the ability of glioma cells to form colonies was also determined. As shown in Fig. 2B , the result showed that silencing of SPOCK1 significantly decreased the number of colonies formed by U87 MG cells. Overexpression of SPOCK1, on the contrary, increasing colony formation in U251 cells. Moreover, the cell cycle progression was detected by flow cytometric analysis (Fig. 2C) . The results demonstrated that silencing of SPOCK1 resulted in a larger fraction of the population in the G1 phase and a significant decrease in the proportion in G2/M phase. Overexpression of SPOCK1 significantly reduced the number of cells arrested in G1 phase. Since PCNA is an index for evaluating the ability of cell proliferation, we subsequently detected the expression of PCNA by immunofluorescence assay. As shown in Fig. 3 , knockdown of SPOCK1 significantly downregulated the expression of PCNA in U87 MG cells. On the contrary, overexpression of SPOCK1 upregulated the expression of PCNA in U251 cells. The above findings provide evidence that SPOCK1 as an oncogene may promote glioma cell growth.
Effect of SPOCK1 on glioma cells apoptosis.
To further explore the mechanism of SPOCK1 in tumor growth, we focused on the role of SPOCK1 in cell apoptosis. As assessed by Annexin v-FITC and PI staining and shown in Fig. 4A , knockdown of SPOCK1 induced obvious apoptosis in U87 MG cells. While the apoptosis was inhibited by SPOCK1 overexpression in U251 cells. Moreover, as shown in Fig. 4B , the nuclear morphological changes in the apoptotic cells were revealed by the Hoechst 33342 staining. Silencing of SPOCK1 resulted in brighter chromatin condensation and nuclear fragmentation of the nuclei, which was significantly suppressed by SPOCK1 overexpression. To further confirm the effect of SPOCK1 on apoptosis, a number of apoptosis related proteins were determined. The results showed that knockdown of SPOCK1 induced increase in expression levels of Bax, cleaved PARP and cleaved caspase-3 and decreased expression of Bcl-2 in U87 MG cells. The expression changes of these apoptosis related proteins were inverted when SPOCK1 was overexpressed in U251 cells. These data indicated that SPOCK1 promotes glioma cell growth by reducing cell apoptosis.
Effect of SPOCK1 on glioma cells migration and invasion.
Cell migration capacity was assessed by wound healing assay.
As shown in Fig. 5A , knockdown of SPOCK1 obviously inhibited the migration capacity of U87 MG cells. When SPOCK1 was overexpressed in U251 cells, the migration capacity was increased significantly. Moreover, the invasive capacity was assessed by transwell assay and shown in Fig. 5B . The results were similar to the changes in migration ability that was inhibited by SPOCK1 silencing and promoted by SPOCK1 overexpression. To further confirm the effect of SPOCK1 on metastasis, the activity and expression of MMP9 and MMP2 was determined by gelatin zymography and western blotting. As shown in Fig. 6A , the activity of MMP9 and MMP2 was restrained by SPOCK1 silencing in U87 MG cells. While overexpression of SPOCK1 could promote the activity of MMP9 and MMP2. The changes of MMP9 and MMP2 expression were similar to those of MMP9 and MMP2 activity (Fig. 6B) .
Effect of SPOCK1 on PI3K/AKT and Wnt/β-catenin signaling pathways. Since PI3K/AKT and Wnt/β-catenin signaling pathways are associated intimately with proliferation and metastasis of cancer cells, the effect of SPOCK1 on PI3K/AKT and Wnt/β-catenin signaling pathways was evaluated. As shown in Fig. 7 , knockdown of SPOCK1 significantly suppressed the protein levels of p-PI3K, p-AKT, Wnt and β-catenin in U87 MG cells, which could be reversed when SPOCK1 was overexpressed in U251 cells. Moreover, the downstream targets of Wnt/β-catenin were also assessed. The results indicated that the protein levels of c-MYC and cyclin D1 were decreased by SPOCK1 silencing, which were increased obviously when SPOCK1 was overexpressed.
Discussion
Glioma is the most common malignancy in the central nervous system, and is the most aggressive and progressive. Because of the poor prognosis and high fatality, glioma severely threatens life and health of patients. The malignant transformation of neurogliocyte and neurone is a complicated process, involving a large number of oncogenes and tumor suppressor genes. Increasing evidence has demonstrated that SPOCK1 as an oncogene promoted various cancer cell proliferation and invasion. We investigated the effect of SPOCK1 on glioma cells proliferation, migration and invasion, which provide a potential therapeutic target as well as a prognostic marker for glioma.
Malignant proliferation is one of the most significant features of tumor cells. Infinite proliferation and anti-apoptosis are two important malignant phenotypes of glioma. In the malignant process of glioma, the tumor cell density is increased with significant nuclear division and atypia (12, 13) . In our present study, the effect of SPOCK1 on glioma cell malignant proliferation was investigated. As assayed by CCK8, the proliferation of glioma cells was obviously inhibited by SPOCK1 silencing. Then clone formation ability Proliferating cell nuclear antigen (PCNA) is a nuclear protein, expressed in proliferative cells only. The synthesis of PCNA has close relation with cellular proliferation cycle, which is increased rapidly in late G1 phase and peaked in S phase. Previous research found that the level of PCNA is relative to the tumor type and clinical stage of the central nervous system tumors (14) . Another study found that inhibition of PCNA could suppress DNA replication and prevent cells from going into proliferation period (15) . In our present study, the expression level of PCNA was decreased by SPOCK1 silencing, while increased when SPOCK1 was overexpressed.
Apoptosis inhibition or escape is another feature of malignant tumor cells. We also observed SPOCK1 effects on the apoptosis of glioma cells. Our results indicated that knockdown of SPOCK1 induced cell apoptosis significantly, which could be suppressed by overexpression of SPOCK1. Cell apoptosis is regulated by a series of apoptosis-related genes, the most significant of which are Bcl-2 and caspase gene families. Bcl-2 is an important member of Bcl-2 gene family and is also an apoptosis suppressor gene. Bcl-2 is expressed in brain tumors, which was significantly positively related to the degree of tumor malignancy (16, 17) . Bax is another apoptosis gene in Bcl-2 family, which and can inhibit the anti-apoptosis effect of Bcl-2. The survival of the cells is determined by the ratio of Bcl-2/Bax (18, 19) . Caspase-3, an executioner caspase, plays a key role in the execution phase of apoptosis by cleaving many key cellular proteins, such as PARP (20, 21) . According to our results, silencing of SPOCK1 decreased the ratio of Bcl-2/Bax and promoted the expression of cleaved caspase-3 and PARP. Overexpression of SPOCK1 resulted in the increased ratio of Bcl-2/Bax and lower expression of cleaved caspase-3 and PARP.
The metastasis and recurrence are the major prognostic factors of cancer patients. Metastasis refers to primary malignant tumor cells invading other parts of the body and spreading to other organs, which is one of the fundamental biologic behaviors of tumor. Multiple steps, such as migration and invasion, participate in the process of metastasis of tumors. Our results demonstrated that the migration and invasion of glioma cells was suppressed by silencing of SPOCK1 and promoted by SPOCK1 overexpression. Matrix metalloproteinases (MMPs), a family of endopeptidases, could degrade extracellular matrix. Recent research found that the degradation of extracellular matrix and basement membrane played key roles in the invasion and metastasis of tumor, which could be regulated by MMPs (22) . Research also found that the levels of MMPs were positively related to the invasive ability of glioma cells (23) . MMP2 and MMP9 are two important MMPs, the expression levels of which are enhanced in glioma cells (24, 25) . As the glioma malignancy degree increased, the expression of MMP2 and MMP9 was increased (23, 26) . Our results demonstrated that the activity and expression of MMP2 and MMP9 were restrained by SPOCK1 silencing, which could be promoted by SPOCK1 overexpression.
Growing evidence has demonstrated that PI3K/AKT signaling pathway played important roles in the occurrence and development of glioblastoma (27, 28) . As one of the important intracellular signal transduction pathways, PI3K/AKT signaling pathway not only impacts on proliferation and apoptosis of cancer cells, but also has a role in chemotherapy reactions. Recent studies suggest that the inhibitors of PI3K/AKT signaling pathway could fight drug resistance of various cancers (29) (30) (31) . In our present study, the protein levels of p-PI3K, p-AKT were downregulated by knockdown of SPOCK1. While overexpression of SPOCK1 could upregulate the protein levels of p-PI3K, p-AKT. Wnt/β-catenin signaling pathway is a focus of tumor biology. Increasing evidence shows that Wnt/β-catenin signaling pathway is closely related to tumorigenesis. With the deepening of the research, c-MYC and cyclin D1 were found to be target genes of Wnt/β-catenin signaling pathway (32, 33) . These downstream genes were closely related to proliferation and differentiation. It was found that the activation of c-MYC played a role in various tumors, including glioma, lymphoma, lung cancer, and colorectal cancer (34) (35) (36) (37) . Research also found that c-MYC and cyclin D1 was regulated by β-catenin in ovarian cancer (38) . Our present study found that the protein levels of Wnt and β-catenin were decreased by SPOCK1 silencing, and upregulated in SPOCK1 overexpression. The expression levels of c-MYC and cyclin D1 were positively correlated with Wnt/β-catenin.
In conclusion, our results suggest that SPOCK1 may serve as an oncogene in glioma. Overexpression of SPOCK1 promotes glioma cell proliferation, migration and invasion via PI3K/AKT and Wnt/β-catenin signaling pathways, which could be reversed by SPOCK1 silencing. These observations confirm that SPOCK1 may serve as both a treatment target and prognostic indicator for patients with glioma.
